Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Pharmacologic Ascorbate in Mye...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter

Bibliographic Details
Published in:EBioMedicine
Main Authors: Pierre-Christian Violet, Mark Levine
Format: Article
Language:English
Published: Elsevier 2017-04-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396417301019
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352396417301019

Similar Items

  • Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
    by: Jiliang Xia, et al.
    Published: (2017-04-01)
  • Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial
    by: Dagan Coppock, et al.
    Published: (2022-03-01)
  • Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma
    by: John M. Rieth, et al.
    Published: (2024-08-01)
  • Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
    by: Garett J. Steers, et al.
    Published: (2022-05-01)
  • Correction: Coppock et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. <i>Life</i> 2022, <i>12</i>, 453
    by: Dagan Coppock, et al.
    Published: (2022-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs